Updated:
Superorganism
Superorganism is a private equity based in New York, founded 2022; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
Superorganism
Superorganism is a New York-based SEC-registered investment adviser — managing client assets.
General information
Firm type
Private Equity
Year founded
2022
Location
Region
North America
Country
United States
City
New York
Corporate office
San Francisco, CA, United States
Principals
Tom Quigley
Co-Founder
Kevin Webb
Co-Founder
Annie McCluskey
Co-Founder
Kit McDonnell
Co-Founder
Everett Sanderson
Co-Founder
Sector focus
Frequently asked questions
Who makes investment decisions at Superorganism?
The five named co-founders—Tom Quigley, Kevin Webb, Annie McCluskey, Kit McDonnell, and Everett Sanderson—serve as the investment committee. Each brings distinct operational or conservation expertise; Quigley and Webb carry the longest tenures in tech-nature overlap, while McCluskey and Sanderson add institutional science-capital and climate-VC perspectives. The firm's mentor network appears to advise but does not vote on deals.
How does Superorganism source proprietary deal flow?
Superorganism draws pipeline through its 27-person mentor network of conservation technologists and serial entrepreneurs, which includes figures like Beth Shapiro, Topher White, and Keolu Fox. The firm also publishes a monthly biodiversity newsletter and maintains field-research partnerships that surface deep-tech founders working on extinction-driver problems—agriculture, infrastructure monitoring, atmospheric intervention—before they appear at traditional climate-tech demo days.
Does Superorganism participate in fund commitments or only direct deals?
All disclosed activity points to direct pre-seed and seed equity investments. The firm has not indicated any fund-of-funds commitments or LP positions in other venture vehicles. Portfolio companies like Amini, Planet A Foods, and Inversa are structured as direct holdings.
What investment stages does Superorganism target?
Superorganism concentrates on pre-seed and seed rounds, providing first institutional capital to startups at the earliest inflection point. The portfolio companies—such as Spoor (AI for bird detection at wind farms) and Ulysses (kilometer-scale seagrass restoration)—exhibit the technology-readiness levels typical of companies that have moved beyond laboratory proof-of-concept and need initial go-to-market funding.
How is Superorganism related to the conservation non-profit world?
The firm pledges 10% of its own profits to future conservation initiatives, though it is structured as a for-profit venture manager rather than a hybrid impact vehicle. The pledge does not create a separate 501(c)(3) entity; instead it earmarks carried interest and management-company profits for nature funding. The mentor network includes conservation researchers and practitioners, but retains no formal governance rights over investment decisions.
What is Superorganism's known posture on co-investments alongside external GPs?
Superorganism has not publicly structured a formal co-investment program or disclosed sidecar vehicles. Given the pre-seed and seed focus, rounds likely include syndicates with other climate- and biodiversity-focused micro-funds and angel investors, but the firm's website and public disclosures do not name recurring syndicate partners.
Which sectors does Superorganism explicitly avoid?
The firm's biodiversity mandate creates a negative screen against companies that exacerbate extinction drivers without a measurable remediation or disruption angle. Traditional extractive industries, industrial agriculture without regenerative transition roadmaps, and pure software plays that do not intersect with biodiversity outcomes would fall outside its stated scope. No explicit restricted-sector list is published, but the investment thesis filters out any startup that does not materially address an extinction driver.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: